Department of Chemistry, Research Institute for Natural Sciences, Hanyang University, Seoul, Korea.
Cancer Sci. 2013 Sep;104(9):1172-7. doi: 10.1111/cas.12207. Epub 2013 Jun 24.
Glioblastoma remains an incurable brain disease due to the prevalence of its recurrence. Considerable evidence suggests that glioma stem-like cells are responsible for glioma relapse after treatment, which commonly involves ionizing radiation. Here, we found that fractionated ionizing radiation (2 Gy/day for 3 days) induced glioma stem-like cell expansion and resistance to anticancer treatment such as cisplatin (50 μM) or taxol (500 nM), or by ionizing radiation (10 Gy) in both glioma cell lines (U87, U373) and patient-derived glioma cells. Of note, concomitant increase of nitric oxide production occurred with the radiation-induced increase of the glioma stem-like cell population through upregulation of inducible nitric oxide synthase (iNOS). In line with this observation, downregulation of iNOS effectively reduced the glioma stem-like cell population and decreased resistance to anticancer treatment. Collectively, our results suggest that targeting iNOS in combination with ionizing radiation might increase the efficacy of radiotherapy for glioma treatment.
由于复发性高,胶质母细胞瘤仍然是一种无法治愈的脑部疾病。有大量证据表明,胶质瘤干细胞是治疗后胶质瘤复发的罪魁祸首,而治疗通常涉及电离辐射。在这里,我们发现,分次电离辐射(每天 2 Gy,共 3 天)可诱导胶质瘤干细胞扩增,并对顺铂(50 μM)或紫杉醇(500 nM)等抗癌药物治疗产生耐药性,或者对两种胶质瘤细胞系(U87、U373)和患者来源的胶质瘤细胞中的电离辐射(10 Gy)产生耐药性。值得注意的是,通过诱导型一氧化氮合酶(iNOS)的上调,一氧化氮的产生与辐射诱导的胶质瘤干细胞群体增加同时发生。与这一观察结果一致的是,iNOS 的下调可有效减少胶质瘤干细胞群体,并降低对抗癌治疗的耐药性。总的来说,我们的结果表明,iNOS 靶向联合电离辐射可能会提高放疗治疗脑肿瘤的疗效。